Kobayashi Pharmaceutical Statistics

Total Valuation

Kobayashi Pharmaceutical has a market cap or net worth of JPY 421.87 billion. The enterprise value is 362.65 billion.

Market Cap	421.87B
Enterprise Value	362.65B

Important Dates

The next estimated earnings date is Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Kobayashi Pharmaceutical has 74.34 million shares outstanding. The number of shares has decreased by -2.02% in one year.

Shares Outstanding	74.34M
Shares Change (YoY)	-2.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.48%
Owned by Institutions (%)	11.60%
Float	39.41M

Valuation Ratios

The trailing PE ratio is 30.58 and the forward PE ratio is 28.24.

PE Ratio	30.58
Forward PE	28.24
PS Ratio	2.46
PB Ratio	2.01
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.40, with an EV/FCF ratio of -35.47.

EV / Earnings	26.07
EV / Sales	2.10
EV / EBITDA	11.40
EV / EBIT	14.69
EV / FCF	-35.47

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.01.

Current Ratio	2.88
Quick Ratio	2.08
Debt / Equity	0.01
Debt / EBITDA	0.04
Debt / FCF	-0.11
Interest Coverage	705.34

Financial Efficiency

Return on equity (ROE) is 6.65% and return on invested capital (ROIC) is 7.34%.

Return on Equity (ROE)	6.65%
Return on Assets (ROA)	5.84%
Return on Capital (ROIC)	7.34%
Revenue Per Employee	48.94M
Profits Per Employee	3.94M
Employee Count	3,534
Asset Turnover	0.65
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-15.00%
50-Day Moving Average	5,562.36
200-Day Moving Average	5,796.14
Relative Strength Index (RSI)	50.60
Average Volume (20 Days)	426,685

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kobayashi Pharmaceutical had revenue of JPY 172.97 billion and earned 13.91 billion in profits. Earnings per share was 185.56.

Revenue	172.97B
Gross Profit	94.64B
Operating Income	24.69B
Pretax Income	18.75B
Net Income	13.91B
EBITDA	31.81B
EBIT	24.69B
Earnings Per Share (EPS)	185.56

Full Income Statement

Balance Sheet

The company has 60.36 billion in cash and 1.14 billion in debt, giving a net cash position of 59.22 billion or 796.62 per share.

Cash & Cash Equivalents	60.36B
Total Debt	1.14B
Net Cash	59.22B
Net Cash Per Share	796.62
Equity (Book Value)	209.73B
Book Value Per Share	2,821.31
Working Capital	86.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.64 billion and capital expenditures -26.86 billion, giving a free cash flow of -10.23 billion.

Operating Cash Flow	16.64B
Capital Expenditures	-26.86B
Free Cash Flow	-10.23B
FCF Per Share	-137.55

Full Cash Flow Statement

Margins

Gross margin is 54.72%, with operating and profit margins of 14.27% and 8.04%.

Gross Margin	54.72%
Operating Margin	14.27%
Pretax Margin	10.84%
Profit Margin	8.04%
EBITDA Margin	18.39%
EBIT Margin	14.27%
FCF Margin	-5.91%

Dividends & Yields

This stock pays an annual dividend of 101.00, which amounts to a dividend yield of 1.77%.

Dividend Per Share	101.00
Dividend Yield	1.77%
Dividend Growth (YoY)	6.32%
Years of Dividend Growth	6
Payout Ratio	54.51%
Buyback Yield	2.02%
Shareholder Yield	3.79%
Earnings Yield	3.27%
FCF Yield	-2.42%

Dividend Details

Stock Splits

The last stock split was on June 28, 2016. It was a forward split with a ratio of 2.

Last Split Date	Jun 28, 2016
Split Type	Forward
Split Ratio	2

Scores

Kobayashi Pharmaceutical has an Altman Z-Score of 7.96.

Altman Z-Score	7.96
Piotroski F-Score	n/a